Monday, 24 June 2019

Conatus Pharma to explore options as liver disease drug fails trial

Conatus Pharmaceuticals Inc said on Monday it plans to explore options and implement a restructuring plan after its liver disease drug failed in a mid-stage trial.


Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)